- Medicina Experimental
Departament
Publications dans lesquelles il/elle collabore avec ROSA MARIA MARTI LABORDA (20)
2023
-
Protocol to characterize the melanoma tumor immune microenvironment in mice from single cell to flow cytometry analysis
STAR Protocols, Vol. 4, Núm. 4
2022
-
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors
British Journal of Cancer
2021
-
Brafv600e mutant allele frequency (Maf) influences melanoma clinicopathologic characteristics
Cancers, Vol. 13, Núm. 20
-
Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification
Acta Dermato-Venereologica, Vol. 101, Núm. 11
2020
-
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265
-
T-type calcium channels: A potential novel target in melanoma
Cancers, Vol. 12, Núm. 2
2019
-
In vitro cell migration, invasion, and adhesion assays: From cell imaging to data analysis
Frontiers in Cell and Developmental Biology, Vol. 7, Núm. JUN
2018
-
T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1
Pigment Cell and Melanoma Research, Vol. 31, Núm. 4, pp. 484-495
2017
-
Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma
British Journal of Dermatology, Vol. 176, Núm. 5, pp. 1247-1258
2016
-
2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels
Pigment Cell and Melanoma Research, Vol. 29, Núm. 3, pp. 352-371
2015
-
Calcium channel expression and applicability as targeted therapies in melanoma
BioMed Research International, Vol. 2015
2013
-
T-type calcium channel blockers inhibit autophagy and promote apoptosis of malignant melanoma cells
Pigment Cell and Melanoma Research, Vol. 26, Núm. 6, pp. 874-885
2012
-
Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
Molecular Oncology, Vol. 6, Núm. 5, pp. 530-541
-
Functional expression of voltage-gated calcium channels in human melanoma
Pigment Cell and Melanoma Research, Vol. 25, Núm. 2, pp. 200-212
-
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
International Journal of Cancer, Vol. 130, Núm. 4, pp. 967-978
-
New therapeutic targets in melanoma
Actas Dermo-Sifiliograficas, Vol. 103, Núm. 7, pp. 579-590
2009
-
Expression of somatostatin receptors in human melanoma cell lines: Effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation
Journal of International Medical Research, Vol. 37, Núm. 6, pp. 1813-1822
2008
-
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells
Anti-Cancer Drugs, Vol. 19, Núm. 2, pp. 115-124
-
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines
British Journal of Dermatology, Vol. 158, Núm. 3, pp. 496-504
-
Targeted therapies in gynecologic cancers and melanoma
Seminars in Diagnostic Pathology, Vol. 25, Núm. 4, pp. 262-273